Dar Al Dawa Development and Investment Co. Ltd. Stock price

Equities

DADI

JO4101211012

Pharmaceuticals

End-of-day quote Amman S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
1.29 JOD -0.77% Intraday chart for Dar Al Dawa Development and Investment Co. Ltd. -1.53% -2.27%
Sales 2021 51.77M 73.12M Sales 2022 60.36M 85.25M Capitalization 37.45M 52.9M
Net income 2021 1M 1.41M Net income 2022 2M 2.82M EV / Sales 2021 1.33 x
Net Debt 2021 28.58M 40.37M Net Debt 2022 25.39M 35.86M EV / Sales 2022 1.04 x
P/E ratio 2021
36.9 x
P/E ratio 2022
16.1 x
Employees 930
Yield 2021 *
-
Yield 2022
4.67%
Free-Float 43.64%
More Fundamentals * Assessed data
Dynamic Chart
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
Dar Al Dawa Development and Investment Co. Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2019 CI
More news
1 day-0.77%
1 week-1.53%
Current month-2.27%
1 month-3.01%
3 months-2.27%
Current year-2.27%
More quotes
1 week
1.27
Extreme 1.27
1.30
1 month
1.27
Extreme 1.27
1.36
Current year
1.25
Extreme 1.25
1.36
1 year
0.99
Extreme 0.99
1.39
3 years
0.95
Extreme 0.95
1.54
5 years
0.91
Extreme 0.91
1.54
10 years
0.89
Extreme 0.89
3.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 22-01-14
Director of Finance/CFO 46 -
Chief Operating Officer 61 21-11-30
Members of the board TitleAgeSince
Director/Board Member 58 18-03-27
Chairman 62 -
Chairman 76 18-12-18
More insiders
Date Price Change Volume
24-03-27 1.29 -0.77% 175
24-03-26 1.3 +0.78% 98,855
24-03-25 1.29 0.00% 7,300
24-03-24 1.29 -1.53% 8,350
24-03-21 1.31 0.00% 11,364

End-of-day quote Amman S.E., March 26, 2024

More quotes
Dar Al Dawa Development and Investment Company PSC is a Jordan-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical and consumer health products. The Company's main activities are producing medical, chemical and pharmaceutical products, and importing pharmaceutical products. The Company operates an integrated network of 11 manufacturing facilities spread across Jordan, Middle East and North Africa region, as well as Romania. Its Pharmaceutical Development Unit focuses on the process developing of various dosage forms including tablets, capsules, liquids, dry suspensions, suppositories, creams, ointments, gels, parenterals, ophthalmic and nasal preparations. The Analytical Research unit engages in the analytical method development, validation, physiochemical characterization and stability studies.
More about the company
  1. Stock
  2. Equities
  3. Stock Dar Al Dawa Development and Investment Co. Ltd. - Amman S.E.